H. Lundbeck A/S (CPH:HLUN.B)
40.10
-0.22 (-0.55%)
Sep 2, 2025, 4:59 PM CET
H. Lundbeck Revenue
H. Lundbeck had revenue of 6.02B DKK in the quarter ending June 30, 2025, with 10.45% growth. This brings the company's revenue in the last twelve months to 23.52B, up 13.79% year-over-year. In the year 2024, H. Lundbeck had annual revenue of 22.00B with 10.51% growth.
Revenue (ttm)
23.52B
Revenue Growth
+13.79%
P/S Ratio
1.63
Revenue / Employee
4.13M
Employees
5,707
Market Cap
38.42B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 22.00B | 2.09B | 10.51% |
Dec 31, 2023 | 19.91B | 1.67B | 9.13% |
Dec 31, 2022 | 18.25B | 1.95B | 11.95% |
Dec 31, 2021 | 16.30B | -1.37B | -7.77% |
Dec 31, 2020 | 17.67B | 636.00M | 3.73% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk | 311.94B |
Coloplast | 27.87B |
Genmab | 23.16B |
Demant | 22.59B |
ALK-Abelló | 5.86B |
Zealand Pharma | 9.11B |
Ambu A/S | 5.96B |
Bavarian Nordic | 6.46B |